201 related articles for article (PubMed ID: 19231017)
1. Partial virological response to nucleos(t)ide analogues in naïve patients with chronic hepatitis B: From guidelines to field practice.
Lampertico P
J Hepatol; 2009 Apr; 50(4):644-7. PubMed ID: 19231017
[No Abstract] [Full Text] [Related]
2. Review article: Success and failure of nucleoside and nucleotide analogues in chronic hepatitis B.
Leemans WF; Ter Borg MJ; de Man RA
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():171-82. PubMed ID: 18081660
[TBL] [Abstract][Full Text] [Related]
3. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.
Boni C; Laccabue D; Lampertico P; Giuberti T; Viganò M; Schivazappa S; Alfieri A; Pesci M; Gaeta GB; Brancaccio G; Colombo M; Missale G; Ferrari C
Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241
[TBL] [Abstract][Full Text] [Related]
4. Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.
Reijnders JG; Deterding K; Petersen J; Zoulim F; Santantonio T; Buti M; van Bömmel F; Hansen BE; Wedemeyer H; Janssen HL;
J Hepatol; 2010 Apr; 52(4):493-500. PubMed ID: 20185191
[TBL] [Abstract][Full Text] [Related]
5. Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues.
Papatheodoridis GV
Liver Int; 2011 Jan; 31 Suppl 1():95-103. PubMed ID: 21205145
[TBL] [Abstract][Full Text] [Related]
6. Commentary: combination therapy with two nucleos(t)ide analogues in chronic hepatitis B.
Hadziyannis SJ
Aliment Pharmacol Ther; 2012 Jun; 35(12):1482. PubMed ID: 22582839
[No Abstract] [Full Text] [Related]
7. Efficacy and safety of tenofovir in a kidney transplant patient with chronic hepatitis B and nucleos(t)ide multidrug resistance: a case report.
Shan C; Yin GQ; Wu P
J Med Case Rep; 2014 Aug; 8():281. PubMed ID: 25146249
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus with primary resistance to adefovir.
Chang TT; Lai CL
N Engl J Med; 2006 Jul; 355(3):322-3; author reply 323. PubMed ID: 16855278
[No Abstract] [Full Text] [Related]
9. Regulatory T-cell responses in chronic hepatitis B patients treated with nucleos(t)ide analogs compared with healthy subjects and untreated infected individuals.
Chen LY; Zhu LY; Yang BS; Bi MR; Yan BZ; Wang W; Ma YJ
Hepatogastroenterology; 2012; 59(120):2582-6. PubMed ID: 22626879
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of entecavir and tenofovir in chronic hepatitis B.
Güzelbulut F; Ovünç AO; Oetinkaya ZA; Senates E; Gökden Y; Saltürk AG; Sezikli M; Ozkara S; Cetinkaya F
Hepatogastroenterology; 2012; 59(114):477-80. PubMed ID: 21940383
[TBL] [Abstract][Full Text] [Related]
11. Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the future.
Férir G; Kaptein S; Neyts J; De Clercq E
Rev Med Virol; 2008; 18(1):19-34. PubMed ID: 17966115
[TBL] [Abstract][Full Text] [Related]
12. [Influence of nucleoside analogues resistance on anti-HBV treatment].
Hou JL; Sun J
Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1156-7. PubMed ID: 16029585
[No Abstract] [Full Text] [Related]
13. Treatment of chronic hepatitis B in HIV-infected patients in 2007.
Garcia-Gasco P; Sheldon J; Soriano V
J HIV Ther; 2007 Mar; 12(1):19-23. PubMed ID: 17589392
[No Abstract] [Full Text] [Related]
14. Redetection of HBV lamivudine-resistant mutations in a patient under entecavir therapy, who had been treated sequentially with nucleos(t)ide analogues.
Rodriguez-Frias F; Jardi R; Schaper M; Gimferrer M; Elefsiniotis I; Tabernero D; Esteban R; Buti M
J Med Virol; 2007 Nov; 79(11):1671-3. PubMed ID: 17854030
[TBL] [Abstract][Full Text] [Related]
15. [Current treatment of hepatitis B infection: where do the new nucleos(t)ide analogues fit in?].
Fuentes Olmo J; Uribarrena Amézaga R
Gastroenterol Hepatol; 2011; 34(7):492-503. PubMed ID: 21550145
[TBL] [Abstract][Full Text] [Related]
16. [The use of nucleotide analogues in treating patients with chronic hepatitis B].
Wei L; Feng B
Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):380-1. PubMed ID: 16732918
[No Abstract] [Full Text] [Related]
17. [Efficacy and treatment strategy for drug resistances of nucleos(t)ide analogues for chronic hepatitis B].
Hosaka T; Suzuki F; Kumada H
Nihon Shokakibyo Gakkai Zasshi; 2011 Feb; 108(2):210-4. PubMed ID: 21307624
[No Abstract] [Full Text] [Related]
18. [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
Benhamou Y
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S22-5. PubMed ID: 17075492
[No Abstract] [Full Text] [Related]
19. Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding.
Giles M; Visvanathan K; Sasadeusz J
Antivir Ther; 2011; 16(5):621-8. PubMed ID: 21817183
[TBL] [Abstract][Full Text] [Related]
20. [Problems of and strategies in nucleotide analogues therapy for chronic hepatitis B].
Hou JL; Zeng GB
Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):381-2. PubMed ID: 16732919
[No Abstract] [Full Text] [Related]
[Next] [New Search]
